Chemours (CC) Long-Term Deferred Tax (2015 - 2026)

Chemours' Long-Term Deferred Tax history runs 12 years deep, the most recent figure standing at $258.0 million for Q1 2026.

• On a quarterly basis, Long-Term Deferred Tax fell 17.57% year-over-year to $258.0 million in Q1 2026; TTM through Mar 2026 was $258.0 million, a 17.57% decrease from a year earlier, with the FY2025 full-year figure at $254.0 million, down 9.29% from the prior year.
• Long-Term Deferred Tax grew to $258.0 million in Q1 2026 per CC's latest filing, from $254.0 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $333.0 million in Q3 2024 and bottomed at $136.0 million in Q3 2022.
• The 5-year median for Long-Term Deferred Tax is $254.0 million (2025), against an average of $241.2 million.
• Across the five-year window, Long-Term Deferred Tax surged 103.68% in 2023 and fell 25.53% in 2025, its largest moves.
• Year by year, Long-Term Deferred Tax stood at $152.0 million in 2022, then surged by 99.34% to $303.0 million in 2023, then decreased by 7.59% to $280.0 million in 2024, then fell by 9.29% to $254.0 million in 2025, then increased by 1.57% to $258.0 million in 2026.
• Per Business Quant, the three latest CC Long-Term Deferred Tax figures stand at $258.0 million (Q1 2026), $254.0 million (Q4 2025), and $248.0 million (Q3 2025).